Delivery Order SPE2DB24D1021-SPE2DB25FEVCY

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,928.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 150 mg Lyrica capsules, a medication used for various health conditions. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $1,670.88 for the supply of LYRICA 300 MG CAPSULE 90S to the agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,170.90 firm fixed price delivery order is for the supply of LYRICA 300 MG CAPSULE 90S, a prescription medication, to support military healthcare programs. The award is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, valued at $1,242.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LYRICA 300 MG CAPSULE 90S, a prescription medication. The award is not associated with a larger contract vehicle, nor does it have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate...
This federal contract award, valued at $2,285.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of 4566078412 - LYRICA 300 MG CAPSULE 90S, with an ultimate completion date of October 11, 2024. The contract is a Firm Fixed Price (FFP) arrangement, and there was no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,453.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of LYRICA 75 mg Capsules, a pharmaceutical product used for various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,732.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of LYRICA 150 MG CAPSULE 90S, a medication used for various medical conditions. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,611.13 firm fixed-price delivery order is for the supply of LYRICA 100 MG CAPSULE 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.34 firm fixed-price delivery order is for the supply of Lyrica 300 mg capsules. The contract has an ultimate completion date of January 7, 2025 and was awarded on January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $11,508.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lyrica 50 mg capsules to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEVCY
    Delivery Order

This federal contract award, valued at $1,179.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYRICA 300 MG CAPSULE 90S, a prescription medication, to support federal healthcare programs.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.

Generated 6/21/25, 9:47 AM